Integrated Proteins approves 1:10 stock split and board reconstitution
Integrated Proteins Limited approved a 1:10 stock split reducing face value to Re 1 to boost liquidity. The board reclassified promoters, accepted resignations, and appointed new directors including Mr. Sandeep Mahadik.

*this image is generated using AI for illustrative purposes only.
Integrated Proteins Limited has approved a 1:10 sub-division of its equity shares, reducing the face value from ₹10 to Re 1 to enhance liquidity and affordability for retail investors. The Board of Directors approved the split at its meeting held on July 9, 2026, subject to shareholder and regulatory approvals. The record date for the sub-division will be intimated subsequently. The authorized share capital will be adjusted to ₹25,00,00,000 divided into 25,00,00,000 equity shares of Re 1 each.
Share Capital Structure
The following table outlines the share capital structure before and after the sub-division:
| Particulars: | Pre Sub-Division | Post Sub-Division |
|---|---|---|
| No. of Shares | 2,50,00,000 | 25,00,00,000 |
| Face Value (₹) | 10 | 1 |
| Total Value (₹) | 25,00,00,000 | 25,00,00,000 |
Promoter Reclassification
The board also approved the reclassification of certain promoter and promoter group shareholders to the 'Public' category, including Vinod Prabhulal Mehta, Amrish Vinod Mehta, and Jyoti Vinodchandra Mehta, subject to a No Objection Certificate from BSE Limited. Additionally, the board accepted the resignations of Mr. Priyansh Tejas Parekh (Independent Director), Ms. Neepa Praful Kothari (Director), and Mr. Vinod Prabhulal Mehta (Executive Director), effective July 9, 2026, citing professional commitments.
Board Reconstitution
To fill the vacancies, the board appointed Mr. Nitish Pratapray Mehta as an Additional Non-Executive Director categorized as an Executive Director, and Mr. Hiren Dhirajlal Shah as an Additional Executive Director. Mr. Sandeep Mahadik was appointed as an Additional Non-Executive Independent Director for a term of five years from July 9, 2026, to June 8, 2031, subject to shareholder approval. The board also reconstituted the Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee with effect from July 9, 2026. The intimation was filed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and confirmed by Shivangi Paliwal, Company Secretary and Compliance Officer.
Historical Stock Returns for Integrated Proteins
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.97% | -0.70% | +4.94% | +360.51% | +240.57% | +4,307.35% |
How will the share split impact trading volumes and liquidity in the short term?
What strategic changes might the new board members bring to the company's growth plans?
How will the reclassification of promoters to the 'Public' category affect governance and shareholding patterns?































